CC
XERS icon

Centiva Capital’s Xeris Biopharma Holdings XERS Stock Holding History

Centiva Capital’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-39,086
Closed -$183K – 1924
2025
Q2 		$183K Sell
39,086
-22,967
-37% -$105K ﹤0.01% 1356
2025
Q1 		$341K Buy
+62,053
New +$250K 0.01% 1015
2024
Q2 		– Sell
-33,589
Closed -$74.2K – 2551
2024
Q1 		$74.2K Sell
33,589
-8,779
-21% -$22.7K ﹤0.01% 1631
2023
Q4 		$99.6K Buy
+42,368
New +$78.2K ﹤0.01% 1585
2021
Q2 		– Sell
-20,605
Closed -$93K – 1655
2021
Q1 		$93K Buy
+20,605
New +$111K ﹤0.01% 1072

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Centiva Capital's XERS Position: Q3 2025 in Review

Centiva Capital sold out of Xeris Biopharma Holdings (XERS) in Q3 2025, closing a stake of 39,086 shares — an estimated $183K sold.

Centiva Capital first reported a position in XERS in Q1 2021 and held it in 5 quarters. The position peaked at $341K in Q1 2025. 230 funds tracked by Wall St. Rank hold XERS as of Q3 2025.

  • Centiva Capital reported no remaining Xeris Biopharma Holdings position as of Q3 2025 after selling out during the quarter.
  • Centiva Capital sold 39,086 Xeris Biopharma Holdings shares in Q3 2025, an estimated $183K.
  • Centiva Capital first reported a position in Xeris Biopharma Holdings in Q1 2021 and held it in 5 quarters.
  • Centiva Capital's Xeris Biopharma Holdings position peaked at $341K in Q1 2025.
  • 230 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.